ProQR's stock jumps on expanded RNA deal with Lilly

Shares of ProQR Therapeutics NV
PRQR,
+ 73.03%
nce 56.3% hauv kev ua lag luam ua ntej rau hnub Thursday tom qab lub tuam txhab tau hais tias nws tau nthuav dav RNA kho nrog Eli Lilly & Co. Inc.
LLY,
-1.49%
tsom mus ua cov tshuaj genetic tshiab. Cov tuam txhab tau hais thawj zaug tias lawv yuav koom tes hauv 2021. Raws li ib feem ntawm kev nthuav dav, Lilly yuav them ProQR them ua ntej ntawm $ 75 lab. ProQR tam sim no tsim nyog rau tag nrho $ 3.75 nphom hauv kev them nyiaj tseem ceeb. ProQR cov Tshuag tau poob 79.4% xyoo dhau los, thaum S&P 500
SPX,
-2.74%
yog nqes 18.6%.